US OptionsDetailed Quotes
PLMR241018P75000
- 4.00
- 0.000.00%
15min DelayClose Sep 27 16:00 ET
0.00High0.00Low
4.00Open4.00Pre Close0 Volume6 Open Interest75.00Strike Price0.00Turnover142.68%IV25.12%PremiumOct 18, 2024Expiry Date0.00Intrinsic Value100Multiplier20DDays to Expiry4.00Extrinsic Value100Contract SizeAmericanOptions Type-0.1916Delta0.0085Gamma23.71Leverage Ratio-0.2128Theta-0.0115Rho-4.54Eff Leverage0.0611Vega
Palomar Holdings Stock Discussion
Sign in to post a comment
4
Recent insider selling of Palomar Holdings stock is seen as a negative sign. Low insider ownership suggests a lack of alignment with shareholders. Combined with identified investment risks, analysts are cautious about the company.
1
Investors' belief in Palomar Holdings' continued market outperformance likely explains its high P/E ratio. Strong future growth prospects justify this ratio and support the share price, but earnings deterioration could impact this outlook.
Palomar's CEO, Mac Armstrong, is thrilled about Bradley's appointment, citing his vast experience in insurance and reinsurance, especially in capital management, corporate development, strategic planning, and mergers and acquisitions, as a significant asset to Palomar and its ongoing Palomar 2X strategy.
Significant insider selling at Palomar Holdings, especially in the last three months, may worry investors. Despite profits, the absence of insider buying in the past year and history of sales calls for careful investment consideration.
The fact that insiders have been selling stock, coupled with no recorded insider purchases over the last three months, may suggest that the shares aren't cheap. While insider ownership shows some alignment between management and smaller shareholders, the insider selling activity calls for careful consideration prior to investing.
Upgrades
• $Brixmor Property Group Inc (BRX.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $25 (from $27)
• $The Cigna Group (CI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $296 (from $283)
• $Enerpac Tool (EPAC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $23 (from $22)
• $Equity Residential (EQR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $79 (from $95)
• $Extra Space Storage Inc (EXR.US)$ : JPMorga...
• $Brixmor Property Group Inc (BRX.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $25 (from $27)
• $The Cigna Group (CI.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $296 (from $283)
• $Enerpac Tool (EPAC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $23 (from $22)
• $Equity Residential (EQR.US)$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $79 (from $95)
• $Extra Space Storage Inc (EXR.US)$ : JPMorga...
15
1
No comment yet
coolncrazy : What do you think about LEGN with takeover speculation Watching Legend Biotech; Traders Circulate Un - moomoo
FlexibleTrader OP coolncrazy : Company not bad ! How much buyers trying to bid price at if over 100$ not bad … I don’t like to risk too much on speculative plays these days ..
coolncrazy : it will be an interesting watch on Monday. like what you say...stay away from speculations
FlexibleTrader OP coolncrazy : You can throw some money if rewards on your side , trading below my mental entry so not too much excited anyway will give look next eeek